drugset / Trial / NCT04971798

Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis

NCT04971798 ↗

Phase 0 Unknown 12 enrolled General Therapeutics
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of intraarticular injection of Cell-free Stem Cell-derived Extract Formulation for treatment of knee osteoarthritis symptoms.

Timeline

Start
2023-01-01
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject cell-free stem cell-derived extract Other / unclassified — Other

Indications